Sex-based comparison of CD4+ T cell DNA methylation in lupus reveals proinflammatory epigenetic changes in men.


Journal

Clinical immunology (Orlando, Fla.)
ISSN: 1521-7035
Titre abrégé: Clin Immunol
Pays: United States
ID NLM: 100883537

Informations de publication

Date de publication:
10 2022
Historique:
received: 28 06 2022
revised: 29 08 2022
accepted: 01 09 2022
pubmed: 9 9 2022
medline: 21 9 2022
entrez: 8 9 2022
Statut: ppublish

Résumé

Systemic lupus erythematosus (SLE) is more common in women than men, but the disease is more severe when it affects men. Lupus CD4+ T cells demonstrate dysregulated DNA methylation patterns. The purpose of this study was to investigate genome-wide CD4+ T cell differential DNA methylation between men (n = 12) and women (n = 10) with SLE. DNA methylation was evaluated using the Infinium MethylationEPIC array, and differences between male versus female SLE patients were calculated with probe-wise linear regressions with adjustment for age and disease activity. We identified 198 hypomethylated and 108 hypermethylated CpG sites in CD4+ T cells isolated from male compared to female SLE patients, annotated to 201 and 102 genes, respectively. A great proportion of these genes were related to apoptosis and immune functions. Among differentially methylated genes, CASP10, which is involved in the extrinsic apoptotic pathway, and multiple genes involved in T cell function and differentiation such as ELAVL1, UHRF1, and SMAD2, were hypomethylated in men compared to women with SLE. Importantly, network analysis of differentially methylated genes revealed a pattern consistent with increased activation of ROCK, PP2A, PI3K, and ERK1/ERK2 in men compared to women with SLE. These data provide epigenetic evidence suggesting activation of key T cell pathways in men compared to women with SLE and shed new light into possible mechanisms underlying increased SLE disease severity in men.

Identifiants

pubmed: 36075396
pii: S1521-6616(22)00197-8
doi: 10.1016/j.clim.2022.109116
pmc: PMC10236946
mid: NIHMS1903929
pii:
doi:

Substances chimiques

CCAAT-Enhancer-Binding Proteins 0
UHRF1 protein, human EC 2.3.2.27
Ubiquitin-Protein Ligases EC 2.3.2.27

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

109116

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI097134
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have declared that no conflict of interest exists.

Références

JCI Insight. 2020 Nov 19;5(22):
pubmed: 33108347
Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16814-9
pubmed: 25385601
Trends Cell Biol. 2008 May;18(5):210-9
pubmed: 18394899
Nat Immunol. 2014 Jun;15(6):571-9
pubmed: 24777532
Nat Rev Rheumatol. 2020 Sep;16(9):514-524
pubmed: 32759997
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
J Biol Chem. 1996 Apr 5;271(14):8144-51
pubmed: 8626503
Cancer Med. 2022 Mar;11(6):1454-1464
pubmed: 35128835
Curr Opin Cell Biol. 2017 Apr;45:62-71
pubmed: 28343126
Rheumatology (Oxford). 2021 Dec 24;61(1):367-376
pubmed: 33871600
J Autoimmun. 2012 May;38(2-3):J216-22
pubmed: 22305513
Clin Immunol. 2017 Dec;185:95-99
pubmed: 27109641
Lupus. 2010 Feb;19(2):119-29
pubmed: 19946032
Nat Rev Immunol. 2009 Sep;9(9):630-44
pubmed: 19696767
Arthritis Rheumatol. 2021 Jun;73(6):991-996
pubmed: 33474834
J Autoimmun. 2013 Jun;43:78-84
pubmed: 23623029
Nat Immunol. 2020 Jun;21(6):605-614
pubmed: 32367037
Cell. 1999 Jul 9;98(1):47-58
pubmed: 10412980
J Immunol. 2021 Apr 15;206(8):1719-1728
pubmed: 33762326
Nat Rev Dis Primers. 2016 Jun 16;2:16039
pubmed: 27306639
Clin Epigenetics. 2021 Feb 10;13(1):31
pubmed: 33568199
Genes Immun. 2009 Jul;10(5):446-56
pubmed: 19440200
Cancer Res. 2006 Aug 15;66(16):8131-8
pubmed: 16912191
Epigenetics. 2011 May;6(5):593-601
pubmed: 21436623
Clin Immunol. 2000 Oct;97(1):50-8
pubmed: 10998317
Commun Integr Biol. 2011 May;4(3):267-75
pubmed: 21980556
Ann Rheum Dis. 2012 May;71(5):694-9
pubmed: 22110124
EMBO J. 2009 May 6;28(9):1271-82
pubmed: 19322201
Arthritis Rheum. 1997 Sep;40(9):1725
pubmed: 9324032
Nucleic Acids Res. 2021 Jun 21;49(11):6053-6068
pubmed: 33939809
Cell. 2017 Apr 20;169(3):381-405
pubmed: 28431241
J Clin Invest. 2005 Nov;115(11):3193-204
pubmed: 16224536
Proc Natl Acad Sci U S A. 2019 Jan 15;116(3):982-987
pubmed: 30593560

Auteurs

Mustafa Ali (M)

University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.

Patrick Coit (P)

Division of Rheumatology, Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USA.

Amr H Sawalha (AH)

Division of Rheumatology, Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USA; Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, PA, USA; Lupus Center of Excellence, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA. Electronic address: asawalha@pitt.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH